Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists

Details for Australian Patent Application No. 2006306140 (hide)

Owner Bristol-Myers Squibb Company

Inventors Washburn, William N.; Hernandez, Andres S.; Robl, Jeffrey A.; Manfredi, Mark C.

Agent A J Park

Pub. Number AU-A-2006306140

PCT Pub. Number WO2007/050726

Priority 60/730,453 26.10.05 US; 11/586,255 25.10.06 US

Filing date 26 October 2006

Wipo publication date 3 May 2007

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/522 (2006.01)

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050726 Priority application(s): WO2007/050726

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306146-Indazole derivatives that inhibit TRPV1 receptor

2006306139-Dimercaptan terminated polythioether polymers and methods for making and using the same